Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 037 IN DEXTROSE 5 AND SODIUM CHLORIDE 0 11 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 037 IN DEXTROSE 5 AND SODIUM CHLORIDE 0 11 IN PLASTIC CONTAINER.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.037% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Dextrose 5% provides free water and calories to correct carbohydrate depletion and osmotic diuresis. Potassium chloride replaces potassium ions to maintain cellular membrane potential, nerve impulse conduction, and muscle contraction. Sodium chloride 0.11% provides sodium and chloride ions to maintain extracellular fluid volume and osmolality.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion; rate and volume determined by electrolyte needs and fluid status. Typical maintenance: 1-2 mEq/kg/day potassium chloride, administered at a rate not exceeding 10-20 mEq/h via peripheral line or up to 40 mEq/h via central line. This product provides 0.037% KCl (5 mEq/L), 5% dextrose, and 0.11% NaCl (19 mEq/L Na+).
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Potassium: not applicable as an element; distribution half-life ~1 h. Dextrose: minutes. Sodium: regulated with t1/2 of ~1-2 h for acute load.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Renal: >90% of potassium is excreted via kidneys, with minor fecal loss (~10%). Dextrose and sodium are fully metabolized or renally excreted.
Category C
Category A/B
Electrolyte
Electrolyte